These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 29274830)

  • 1. The past, present, and future of selective progesterone receptor modulators in the management of uterine fibroids.
    Singh SS; Belland L; Leyland N; von Riedemann S; Murji A
    Am J Obstet Gynecol; 2018 Jun; 218(6):563-572.e1. PubMed ID: 29274830
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Progesterone and progesterone receptor modulators in the management of symptomatic uterine fibroids.
    Talaulikar VS; Manyonda I
    Eur J Obstet Gynecol Reprod Biol; 2012 Dec; 165(2):135-40. PubMed ID: 22901974
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ulipristal acetate for uterine fibroid-related symptoms.
    Puchar A; Luton D; Koskas M
    Drugs Today (Barc); 2015 Nov; 51(11):661-7. PubMed ID: 26744741
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The use of selective progestin receptor modulators (SPRMs) and more specifically ulipristal acetate in the practice of gynaecology.
    Rozenberg S; Praet J; Pazzaglia E; Gilles C; Manigart Y; Vandromme J
    Aust N Z J Obstet Gynaecol; 2017 Aug; 57(4):393-399. PubMed ID: 28567743
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of Medical Management for Uterine Leiomyomas.
    Kashani BN; Centini G; Morelli SS; Weiss G; Petraglia F
    Best Pract Res Clin Obstet Gynaecol; 2016 Jul; 34():85-103. PubMed ID: 26796059
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An Evidence-based Approach to the Medical Management of Fibroids: A Systematic Review.
    Bartels CB; Cayton KC; Chuong FS; Holthouser K; Arian SE; Abraham T; Segars JH
    Clin Obstet Gynecol; 2016 Mar; 59(1):30-52. PubMed ID: 26756261
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selective progesterone receptor modulators: an update.
    Benagiano G; Bastianelli C; Farris M; Brosens I
    Expert Opin Pharmacother; 2014 Jul; 15(10):1403-15. PubMed ID: 24787486
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ulipristal acetate for use in moderate to severe symptoms of uterine fibroids.
    Talaulikar VS; Manyonda I
    Womens Health (Lond); 2014 Nov; 10(6):565-70. PubMed ID: 25482483
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Applicability of selective progesterone receptor modulators in the treatment of uterine leiomyomata and their future role in the field of gynecology].
    Brazert M; Korman MP; Pawelczyk LA
    Ginekol Pol; 2013 Sep; 84(9):794-800. PubMed ID: 24191519
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Update on medical treatment of uterine fibroids.
    Faustino F; Martinho M; Reis J; Águas F
    Eur J Obstet Gynecol Reprod Biol; 2017 Sep; 216():61-68. PubMed ID: 28732252
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety of treatment of uterine fibroids with the selective progesterone receptor modulator, ulipristal acetate.
    Donnez J; Donnez O; Dolmans MM
    Expert Opin Drug Saf; 2016 Dec; 15(12):1679-1686. PubMed ID: 27740868
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Emerging treatment options for uterine fibroids.
    Donnez J; Arriagada P; Donnez O; Dolmans MM
    Expert Opin Emerg Drugs; 2018 Mar; 23(1):17-23. PubMed ID: 29486606
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Selective progesterone receptor modulator (ulipristal acetate--a new option in the pharmacological treatment of uterine fibroids in women].
    Szamatowicz M; Kotarski J
    Ginekol Pol; 2013 Mar; 84(3):219-22. PubMed ID: 23700851
    [TBL] [Abstract][Full Text] [Related]  

  • 14. With the advent of selective progesterone receptor modulators, what is the place of myoma surgery in current practice?
    Donnez J; Donnez O; Dolmans MM
    Fertil Steril; 2014 Sep; 102(3):640-8. PubMed ID: 25106762
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Place of ulipristal acetate in the management of uterine fibroids: Preoperative treatment or sequential treatment?
    Pourcelot AG; Capmas P; Fernandez H
    J Gynecol Obstet Hum Reprod; 2017 Mar; 46(3):249-254. PubMed ID: 28403922
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selective Progesterone Receptor Modulators for the Medical Treatment of Uterine Fibroids with a Focus on Ulipristal Acetate.
    Rabe T; Saenger N; Ebert AD; Roemer T; Tinneberg HR; De Wilde RL; Wallwiener M
    Biomed Res Int; 2018; 2018():1374821. PubMed ID: 30539001
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selective progesterone receptor modulators: current applications and perspectives.
    Chabbert-Buffet N; Kolanska K; Daraï E; Bouchard P
    Climacteric; 2018 Aug; 21(4):375-379. PubMed ID: 29338440
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The management of uterine leiomyomas.
    Vilos GA; Allaire C; Laberge PY; Leyland N;
    J Obstet Gynaecol Can; 2015 Feb; 37(2):157-178. PubMed ID: 25767949
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cell-type specific actions of progesterone receptor modulators in the regulation of uterine leiomyoma growth.
    Yoshida S; Ohara N; Xu Q; Chen W; Wang J; Nakabayashi K; Sasaki H; Morikawa A; Maruo T
    Semin Reprod Med; 2010 May; 28(3):260-73. PubMed ID: 20414849
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The use of selective progesterone receptor modulators in the treatment of myomas].
    Šimetka O; Klát J
    Ceska Gynekol; 2016; 81(4):317-320. PubMed ID: 27882756
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.